Product information and disease descriptionPlace of product in therapyApproaches to treatment
Current treatment options and standard of care
8 evidence topics · 6 sources
Tinlarebant (LBS-008)
Stargardt disease type 1
- Manufacturer
- Belite Bio
- Regulatory submission
- NDA submitted June 2026
- Last updated